Dr. Alix Wasilenko is a physician and researcher from Germany, having graduated from the Albert-Ludwigs-Universität Freiburg with her medical degree in 2022. She is a recent graduate of Harvard University, with a masters in public health and research methodology & quantitative methods, focused on biostatistics, bioinformatics and applied mathematics in the biomedical sciences. Her past research lies in the realm of fundamental and computational neuro-oncology, with prior research at the Neurocenter of the University of Freiburg, Harvard University as well as at Harvard affiliate medical institutions. She continues concomitantly her work in transcriptomic profile research in glioblastoma. She is especially interested in the intersection of ethics and technology, especially in the ethical considerations of genomics and AI in healthcare. She is further interested in the ethical aspects of palliative and end-of-life care decisions, and continuing on her past work in public health, the ethical standards upheld in public health interventions, notably questions of equity in access, individual autonomy in relation to public good, and informed consent.

• Genomics and AI in Medicine
• Palliative and End-of-life Care
• Public Health Ethics
• Informed Consent